Keyword: Pharma & Biotech

Plant Construction & Process Technology

Live-Broadcasting of Bioprocesses

10.09.2019 - The quality specifications of biopharmaceuticals are enormous and require a long list of time-consuming analytics. A big disadvantage of these analytics so far was, that their...

Strategy & Management

Continuous Processing

10.09.2019 - Is it possible to learn from other industries or are we doomed to repeat the same mistakes in the pharma sector? Not long ago, I came across a Forbes article which described how...

Plant Construction & Process Technology

Biotechnological Production of Rare Functional Sugar

09.09.2019 - Rare functional sugars provide huge market opportunities. The German company Jennewein Biotechnologie, headquarterd in Rheinbreitbach near Bonn, specializes in in the industrial...

Research & Innovation

Biomade Peptides

09.09.2019 - Peptides make up around 8% of all active pharmaceutical ingredients (APIs). Those molecules are short polymers formed from the linking of ≤100 amino acids. They comprise some of...

Research & Innovation

Coupling Trends in Cultured Meat and Entomophagy

09.09.2019 - Meat produced from cell cultures (i.e., cultured meat) rather than whole animals may be a solution to the problems surrounding our current livestock production system, but it is...

Markets & Companies

Sustainable Chemical Supply Chains

09.09.2019 - The Together for Sustainability (TFS) initiative was launched in 2011 as a joint program of chemical companies for sustainable supply chains. Its goal is to develop and implement a...

Strategy & Management

The Pharma CDMO Challenge

05.09.2019 - The pharmaceutical industry continues to grow and is estimated to be worth $1.5 trillion by 2021. One important driver is the trend towards outsourcing of development and manu...

Markets & Companies

CDMO Market Forces Re-shape of M&A Activity

19.08.2019 - Mergers and acquisitions (M&A) have played a pivotal role in the evolution of the contract development and manufacturing (CDMO) industry. However, after an especially active year...